Literature DB >> 21069317

Wide beam reconstruction for half-dose or half-time cardiac gated SPECT acquisitions: optimization of resources and reduction in radiation exposure.

Claudio Marcassa1, Riccardo Campini, Orazio Zoccarato, Paolo Calza.   

Abstract

PURPOSE: A new iterative reconstruction algorithm (WBR™) has been recently proposed for cardiac single photon emission computed tomography (SPECT). The WBR™ technology is designed to reduce noise, improving lesion identification without affecting the image resolution, allowing SPECT studies with reduced count statistic. This allows for either half-time (HT) or half-dose (HD) cardiac SPECT, with image quality and quantitative data comparable to standard-time (ST) or standard-dose (SD) SPECT. Few data exist on the comparison between conventional filtered backprojection (FBP) and this new algorithm in a clinical setting. The aim of this study was to compare the performance of FBP and WBR™.
METHODS: Phantoms studies were performed to compare spatial resolution and contrast recovery with FBP, ordered subset expectation maximization (OSEM) and WBR™. A group of 92 patients, with different cardiac pathology, scheduled for a stress-rest SPECT were studied: 52 patients (group A) were injected with a SD of tracer and underwent both ST and HT SPECT; 40 patients (group B) were injected with a half dose of tracer and underwent ST SPECT and immediately after an additional SPECT at double time/projection (DT), to compensate for the low count statistic. A 2-day (99m)Tc-sestamibi protocol was used in all patients. SD/ST and HD/DT SPECT were reconstructed with a conventional FBP; SD/HT and HD/ST SPECT were reconstructed with WBR™. The summed stress score (SSS) and summed rest score (SRS) were calculated; the left ventricular ejection fraction (LVEF) was automatically derived.
RESULTS: In group A (SD), no significant differences were observed between ST FBP SPECT and HT WBR™ in SSS (11.1 and 11.7, respectively) and SRS (9.4 and 10.3, respectively, NS). LVEF on rest acquisitions was also comparable (50% on ST SPECT and 49% on HT SPECT, NS); LVEF on post-stress studies in HT SPECT (46%) was lower than ST SPECT (50%), although not statistically significant. In group B (HD), SSS (6.2 in ST and 5.3 in DT) and SRS (4.0 in ST and 3.3 in DT) were also comparable. No differences were documented between ST and DT in rest (47 and 48%, respectively) and stress (48 and 50%, respectively) LVEF.
CONCLUSION: WBR™ performance and image quality were comparable to those of conventional FBP, allowing for either HT or HD studies. The former allows for an increased patient throughput and optimization of resources. The latter modalities would allow for a significant reduction in both patients' and operators' exposure. Further studies are needed to validate the clinical use of this method.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069317     DOI: 10.1007/s00259-010-1654-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  7 in total

1.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

2.  Clinical results of a novel wide beam reconstruction method for shortening scan time of Tc-99m cardiac SPECT perfusion studies.

Authors:  Salvador Borges-Neto; Robert A Pagnanelli; Linda K Shaw; Emily Honeycutt; Shuli C Shwartz; George L Adams; Ralph Edward Coleman
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Automatic quantification of ejection fraction from gated myocardial perfusion SPECT.

Authors:  G Germano; H Kiat; P B Kavanagh; M Moriel; M Mazzanti; H T Su; K F Van Train; D S Berman
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

Review 5.  Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement.

Authors:  Claudio Marcassa; Jeroen J Bax; Frank Bengel; Birger Hesse; Claus L Petersen; Eliana Reyes; Richard Underwood
Journal:  Eur Heart J       Date:  2008-01-17       Impact factor: 29.983

6.  Wide beam reconstruction "quarter-time" gated myocardial perfusion SPECT functional imaging: a comparison to "full-time" ordered subset expectation maximum.

Authors:  E Gordon DePuey; Srinivas Bommireddipalli; John Clark; Linda Thompson; Yossi Srour
Journal:  J Nucl Cardiol       Date:  2009-06-17       Impact factor: 5.952

7.  A multicenter evaluation of a new post-processing method with depth-dependent collimator resolution applied to full-time and half-time acquisitions without and with simultaneously acquired attenuation correction.

Authors:  Carmelo V Venero; Gary V Heller; Timothy M Bateman; A Iain McGhie; Alan W Ahlberg; Deborah Katten; Staci A Courter; Robert J Golub; James A Case; S James Cullom
Journal:  J Nucl Cardiol       Date:  2009-07-07       Impact factor: 5.952

  7 in total
  14 in total

1.  Advances in SPECT camera software and hardware: currently available and new on the horizon.

Authors:  E Gordon DePuey
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

Review 2.  Recent advances in cardiac SPECT instrumentation and system design.

Authors:  Mark F Smith
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

3.  Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study.

Authors:  Orazio Zoccarato; Camilla Scabbio; Elena De Ponti; Roberta Matheoud; Lucia Leva; Sabrina Morzenti; Marco Menzaghi; Riccardo Campini; Claudio Marcassa; Angelo Del Sole; Silvana Garancini; Cinzia Crivellaro; Marco Brambilla; Michela Lecchi
Journal:  J Nucl Cardiol       Date:  2013-11-23       Impact factor: 5.952

4.  The long way to dose reduction in myocardial perfusion imaging.

Authors:  Michela Lecchi; Angelo Del Sole
Journal:  J Nucl Cardiol       Date:  2017-06-30       Impact factor: 5.952

5.  4D reconstruction for low-dose cardiac gated SPECT.

Authors:  Mingwu Jin; Xiaofeng Niu; Wenyuan Qi; Yongyi Yang; Joyoni Dey; Michael A King; Seth Dahlberg; Miles N Wernick
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

6.  Advances in image reconstruction software in nuclear cardiology: Is all that glitters gold?

Authors:  Claudio Marcassa; Orazio Zoccarato
Journal:  J Nucl Cardiol       Date:  2016-05-24       Impact factor: 5.952

7.  A world view of nuclear cardiology practices: Think globally, act locally.

Authors:  Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2016-02-25       Impact factor: 5.952

8.  Automatic evaluation of myocardial perfusion on SPECT: Need for "Normality".

Authors:  Riccardo Liga; Alessia Gimelli
Journal:  J Nucl Cardiol       Date:  2017-10-25       Impact factor: 5.952

9.  Initial multicentre experience of high-speed myocardial perfusion imaging: comparison between high-speed and conventional single-photon emission computed tomography with angiographic validation.

Authors:  Johanne Neill; Elizabeth M Prvulovich; Matthews B Fish; Daniel S Berman; Piotr J Slomka; Tali Sharir; William H Martin; Marcelo F DiCarli; Jack A Ziffer; Jamshed B Bomanji; Dalia Shiti; Simona Ben-Haim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-18       Impact factor: 9.236

10.  Effects of acquisition time and reconstruction algorithm on image quality, quantitative parameters, and clinical interpretation of myocardial perfusion imaging.

Authors:  Lotte H Enevoldsen; Changez A K Menashi; Ulrik B Andersen; Lars T Jensen; Otto M Henriksen
Journal:  J Nucl Cardiol       Date:  2013-08-21       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.